QT
RGLS

Quantbot Technologies’s Regulus Therapeutics RGLS Stock Holding History

Quantbot Technologies’s Portfolio RGLS Stock Details RGLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-4
Closed -$3K – 1301
2016
Q1 		$3K Sell
4
-6
-60% -$4.77K ﹤0.01% 1095
2015
Q4 		$10K Sell
10
-17
-63% -$17K ﹤0.01% 981
2015
Q3 		$20K Buy
+27
New +$27.7K ﹤0.01% 1027
2015
Q1 		– Sell
-3
Closed -$6K – 1302
2014
Q4 		$6K Buy
+3
New +$5.34K ﹤0.01% 1031

Other funds holding RGLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
SDIC
South Dakota Investment Council Sioux Falls, South Dakota $5.84B AUM 30.42% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Quantbot Technologies's RGLS Position: Q2 2016 in Review

Quantbot Technologies sold out of Regulus Therapeutics (RGLS) in Q2 2016, closing a stake of 4 shares — an estimated $3K sold.

Quantbot Technologies first reported a position in RGLS in Q4 2014 and held it in 4 quarters. The position peaked at $20K in Q3 2015. 83 funds tracked by Wall St. Rank hold RGLS as of Q2 2016.

  • Quantbot Technologies reported no remaining Regulus Therapeutics position as of Q2 2016 after selling out during the quarter.
  • Quantbot Technologies sold 4 Regulus Therapeutics shares in Q2 2016, an estimated $3K.
  • Quantbot Technologies first reported a position in Regulus Therapeutics in Q4 2014 and held it in 4 quarters.
  • Quantbot Technologies's Regulus Therapeutics position peaked at $20K in Q3 2015.
  • 83 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q2 2016.

Based on Quantbot Technologies's 13F filing for Q2 2016, filed 2 Aug 2016.